FGH Biotech
Houston, US · Founded 2011 · Delaware corporation
FGH BioTech develops small molecule drugs that regulate SREBP transcription factors and related pathways, targeting the prevention and treatment of metabolic diseases and cancer. The company's work is based on decades of research in fat and energy metabolism.
Founders & leadership
LA
Lufti Abu-ElheigaExecutive
JW
Joe WakilExecutive
Board
AK
Adam KuspaBoard director
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 1 of 2 rounds · 2015–2017
▶$2.1MraisedMay 2018 · 18 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedMay 2018 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lufti Abu-ElheigaExecutive Officer
- Joe WakilExecutive Officer, Director
- Salih J WakilExecutive Officer, Director
- Adam KuspaDirector
- Offering amount
- $4M
- Amount sold
- $2.1M
- Minimum investment
- $12.5K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MofferedNov 2015 · PharmaceuticalsRule 506(b)
▶$2.5MofferedNov 2015 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Adam KuspaDirector
- Lufti Abu-ElheigaExecutive Officer
- Joe WakilExecutive Officer, Director
- Salih J WakilExecutive Officer, Director
- Offering amount
- $2.5M
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does FGH Biotech do?
- FGH BioTech develops small molecule drugs that regulate SREBP transcription factors and related pathways, targeting the prevention and treatment of metabolic diseases and cancer. The company's work is based on decades of research in fat and energy metabolism.
- How much funding has FGH Biotech raised?
- FGH Biotech has disclosed $2.1M raised across 1 of its 2 known rounds.
- Where is FGH Biotech headquartered?
- FGH Biotech is headquartered in Houston, US.